Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Prostate. 2018 06; 78(8):607-615.
View in:
PubMed
subject areas
Aged
Checkpoint Kinase 2
Cohort Studies
Genetic Carrier Screening
Germ-Line Mutation
Heterozygote
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Prognosis
Prostatic Neoplasms
authors with profiles
Kristian Novakovic